Repetitive polypeptides of sequence [(AlaGly)3ProGluGly]16 3a, have been prepared in Escherichia coli as overexpressed recombinant proteins. Replacement of more than 90% of the naturally occurring proline (Pro) residues with 3,4-dehydroproline (Dhp) in sequence 3a was achieved by in vivo expression of the target protein in medium containing Dhp and lacking Pro. The resulting material (3b) was treated with H2O2 or Br2 to yield polymers containing 3,4-dihydroxyproline (Dhy, 3c) and 3,4-dibromoproline (Dbr, 3d), respectively, in place of the Dhp residue. These results represent the first demonstration of the incorporation and modification of alkene functionality in recombinant proteins.
No takes yet. Share an insight, caveat, or question.
Deming et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: